{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:43:32Z","timestamp":1790376212541,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T00:00:00Z","timestamp":1580083200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hereditary hemochromatosis (HHC) is characterized by excessive intestinal iron absorption resulting in a pathological increase of iron levels. Parenchyma damage may be a consequence of iron deposition in affected organs (e.g., liver, pancreas, gonads) as well as bones and joints, leading to osteoporosis with increased fracture risk and arthropathy. Up to date, it is not known whether HHC can also be considered as a risk factor for osteonecrosis. Likewise, the underlying skeletal changes are unknown regarding, e.g., microstructural properties of bone. We aimed to study the spectrum of skeletal complications in HHC and the possible underlying microarchitectural changes. Therefore, we retrospectively analyzed all patients with HHC (<jats:italic>n<\/jats:italic>\u2009=\u200910) presenting in our outpatient clinic for bone diseases. In addition to dual-energy X-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT) was performed and bone turnover markers, 25-OH-D3, ferritin and transferrin saturation were measured. Cortical volumetric bone mineral density (Ct.BMD) and cortical thickness (Ct.Th) were reduced, whereas trabecular microstructure (Tb.Th) and volumetric bone mineral density (Tb.BMD) were preserved compared to age- and gender-adjusted reference values from the literature. Interestingly, the occurrence of bone complications was age dependent; while younger patients presented with osteonecroses or transient bone marrow edema, patients older than 65\u00a0years presented with fractures. Our study provides first insights into altered bone microarchitecture in HHC and sheds new light on the occurrence of osteonecrosis. If available, HR-pQCT is a useful complement to fracture risk assessment and to determine microstructural deterioration and volumetric bone mineralization deficits.<\/jats:p>","DOI":"10.1007\/s00223-020-00658-7","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T07:02:37Z","timestamp":1580108557000},"page":"465-475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Impaired Bone Microarchitecture in Patients with Hereditary Hemochromatosis and Skeletal Complications"],"prefix":"10.1007","volume":"106","author":[{"given":"Nico Maximilian","family":"Jandl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Rolvien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haider","family":"Mussawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Oheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Barvencik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,27]]},"reference":[{"key":"658_CR1","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","volume":"350","author":"A Pietrangelo","year":"2004","unstructured":"Pietrangelo A (2004) Hereditary hemochromatosis\u2014a new look at an old disease. N Engl J Med 350:2383\u20132397","journal-title":"N Engl J Med"},{"key":"658_CR2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ng0896-399","volume":"13","author":"JN Feder","year":"1996","unstructured":"Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399\u2013408","journal-title":"Nat Genet"},{"key":"658_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng1053","volume":"33","author":"A Roetto","year":"2003","unstructured":"Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 33:21\u201322","journal-title":"Nat Genet"},{"key":"658_CR4","doi-asserted-by":"crossref","first-page":"7811","DOI":"10.1074\/jbc.M008923200","volume":"276","author":"C Pigeon","year":"2001","unstructured":"Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276:7811\u20137819","journal-title":"J Biol Chem"},{"key":"658_CR5","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.161296298","volume":"98","author":"RE Fleming","year":"2001","unstructured":"Fleming RE, Sly WS (2001) Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci USA 98:8160\u20138162","journal-title":"Proc Natl Acad Sci USA"},{"key":"658_CR6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2003-03-0672","volume":"102","author":"T Ganz","year":"2003","unstructured":"Ganz T (2003) Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102:783\u2013788","journal-title":"Blood"},{"key":"658_CR7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jbmr.3410","volume":"33","author":"T Schmidt","year":"2018","unstructured":"Schmidt T, Schmidt C, Schmidt FN, Butscheidt S, Mussawy H, Hubert J, Hawellek T, Oehler N, Barvencik F, Lohse AW, Schinke T, Schramm C, Amling M, Rolvien T (2018) Disease duration and stage influence bone microstructure in patients with primary biliary cholangitis. J Bone Miner Res 33:1011\u20131019","journal-title":"J Bone Miner Res"},{"key":"658_CR8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jhep.2018.12.035","volume":"70","author":"T Schmidt","year":"2019","unstructured":"Schmidt T, Schwinge D, Rolvien T, Jeschke A, Schmidt C, Neven M, Butscheidt S, Kriz M, Kunzmann L, Mussawy H, Hubert J, Hawellek T, Ruther W, Oheim R, Barvencik F, Lohse AW, Schramm C, Schinke T, Amling M (2019) Th17 cell frequency is associated with low bone mass in primary sclerosing cholangitis. J Hepatol 70:941\u2013953","journal-title":"J Hepatol"},{"key":"658_CR9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/liv.13730","volume":"38","author":"N Guanabens","year":"2018","unstructured":"Guanabens N, Pares A (2018) Osteoporosis in chronic liver disease. Liver Int 38:776\u2013785","journal-title":"Liver Int"},{"key":"658_CR10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00198-005-1934-0","volume":"16","author":"P Guggenbuhl","year":"2005","unstructured":"Guggenbuhl P, Deugnier Y, Boisdet JF, Rolland Y, Perdriger A, Pawlotsky Y, Chales G (2005) Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos Int 16:1809\u20131814","journal-title":"Osteoporos Int"},{"key":"658_CR11","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00198-008-0701-4","volume":"20","author":"L Valenti","year":"2009","unstructured":"Valenti L, Varenna M, Fracanzani AL, Rossi V, Fargion S, Sinigaglia L (2009) Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos Int 20:549\u2013555","journal-title":"Osteoporos Int"},{"key":"658_CR12","first-page":"1809","volume":"24","author":"L Sinigaglia","year":"1997","unstructured":"Sinigaglia L, Fargion S, Fracanzani AL, Binelli L, Battafarano N, Varenna M, Piperno A, Fiorelli G (1997) Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload. J Rheumatol 24:1809\u20131813","journal-title":"J Rheumatol"},{"key":"658_CR13","doi-asserted-by":"crossref","first-page":"e124486","DOI":"10.1172\/jci.insight.124486","volume":"3","author":"M Wolf","year":"2018","unstructured":"Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W (2018) Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight 3:e124486","journal-title":"JCI Insight"},{"key":"658_CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.toxlet.2009.08.023","volume":"191","author":"K Yamasaki","year":"2009","unstructured":"Yamasaki K, Hagiwara H (2009) Excess iron inhibits osteoblast metabolism. Toxicol Lett 191:211\u2013215","journal-title":"Toxicol Lett"},{"key":"658_CR15","doi-asserted-by":"crossref","first-page":"e0148292","DOI":"10.1371\/journal.pone.0148292","volume":"11","author":"M Doyard","year":"2016","unstructured":"Doyard M, Chappard D, Leroyer P, Roth MP, Loreal O, Guggenbuhl P (2016) Decreased bone formation explains osteoporosis in a genetic mouse model of hemochromatosiss. PLoS ONE 11:e0148292","journal-title":"PLoS ONE"},{"key":"658_CR16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.metabol.2008.02.004","volume":"57","author":"P Guggenbuhl","year":"2008","unstructured":"Guggenbuhl P, Filmon R, Mabilleau G, Basle MF, Chappard D (2008) Iron inhibits hydroxyapatite crystal growth in vitro. Metabolism 57:903\u2013910","journal-title":"Metabolism"},{"key":"658_CR17","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1182\/blood-2009-12-260083","volume":"116","author":"J Tsay","year":"2010","unstructured":"Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, Vogiatzi MG (2010) Bone loss caused by iron overload in a murine model: importance of oxidative stress. Blood 116:2582\u20132589","journal-title":"Blood"},{"key":"658_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/8756-3282(92)90086-C","volume":"13","author":"KS Eyres","year":"1992","unstructured":"Eyres KS, McCloskey EV, Fern ED, Rogers S, Beneton M, Aaron JE, Kanis JA (1992) Osteoporotic fractures: an unusual presentation of haemochromatosis. Bone 13:431\u2013433","journal-title":"Bone"},{"key":"658_CR19","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF01623396","volume":"6","author":"M Duquenne","year":"1996","unstructured":"Duquenne M, Rohmer V, Legrand E, Chappard D, Wion Barbot N, Basle MF, Audran M, Bigorgne JC (1996) Spontaneous multiple vertebral fractures revealed primary haemochromatosis. Osteoporos Int 6:338\u2013340","journal-title":"Osteoporos Int"},{"key":"658_CR20","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.3899\/jrheum.100234","volume":"37","author":"P Richette","year":"2010","unstructured":"Richette P, Ottaviani S, Vicaut E, Bardin T (2010) Musculoskeletal complications of hereditary hemochromatosis: a case-control study. J Rheumatol 37:2145\u20132150","journal-title":"J Rheumatol"},{"key":"658_CR21","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.27712","volume":"62","author":"E Sahinbegovic","year":"2010","unstructured":"Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, Schoniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Stolzel U, Keysser G, Datz C, Schett G, Zwerina J (2010) Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum 62:3792\u20133798","journal-title":"Arthritis Rheum"},{"key":"658_CR22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00003086-199802000-00020","volume":"347","author":"KD Montgomery","year":"1998","unstructured":"Montgomery KD, Williams JR, Sculco TP, DiCarlo E (1998) Clinical and pathologic findings in hemochromatosis hip arthropathy. Clin Orthop Relat Res 347:179\u2013187","journal-title":"Clin Orthop Relat Res"},{"key":"658_CR23","first-page":"376","volume":"32","author":"F Rollot","year":"2005","unstructured":"Rollot F, Wechsler B, du Boutin le TH, De Gennes C, Amoura Z, Hachulla E, Piette JC (2005) Hemochromatosis and femoral head aseptic osteonecrosis: a nonfortuitous association? J Rheumatol 32:376\u2013378","journal-title":"J Rheumatol"},{"key":"658_CR24","first-page":"269","volume":"33","author":"R Jaffres","year":"1966","unstructured":"Jaffres R (1966) Bilateral aseptic osteonecrosis of the hip in a patient with hemochromatosis. Rev Rhum Mal Osteoartic 33:269\u2013272","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"658_CR25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2141.1995.tb05396.x","volume":"91","author":"P Nielsen","year":"1995","unstructured":"Nielsen P, Fischer R, Engelhardt R, Tondury P, Gabbe EE, Janka GE (1995) Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 91:827\u2013833","journal-title":"Br J Haematol"},{"key":"658_CR26","first-page":"153","volume":"3","author":"JWM Gardeniers","year":"1991","unstructured":"Gardeniers JWM (1991) ARCO committee on terminology and staging (report from the Nijmegen meeting). ARCO News Lett 3:153\u2013159","journal-title":"ARCO News Lett"},{"key":"658_CR27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/sarh.2002.33724b","volume":"32","author":"Y Assouline-Dayan","year":"2002","unstructured":"Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32:94\u2013124","journal-title":"Semin Arthritis Rheum"},{"key":"658_CR28","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1093\/gerona\/glv052","volume":"70","author":"P Milovanovic","year":"2015","unstructured":"Milovanovic P, Adamu U, Simon MJ, Rolvien T, Djuric M, Amling M, Busse B (2015) Age- and sex-specific bone structure patterns portend bone fragility in radii and tibiae in relation to osteodensitometry: a high-resolution peripheral quantitative computed tomography study in 385 individuals. J Gerontol A Biol Sci Med Sci 70:1269\u20131275","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"658_CR29","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R (2010) Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25:1468\u20131486","journal-title":"J Bone Miner Res"},{"key":"658_CR30","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1002\/jbmr.2873","volume":"31","author":"LA Burt","year":"2016","unstructured":"Burt LA, Liang Z, Sajobi TT, Hanley DA, Boyd SK (2016) Sex- and site-specific normative data curves for HR-pQCT. J Bone Miner Res 31:2041\u20132047","journal-title":"J Bone Miner Res"},{"key":"658_CR31","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/art.30094","volume":"63","author":"GJ Carroll","year":"2011","unstructured":"Carroll GJ, Breidahl WH, Bulsara MK, Olynyk JK (2011) Hereditary hemochromatosis is characterized by a clinically definable arthropathy that correlates with iron load. Arthritis Rheum 63:286\u2013294","journal-title":"Arthritis Rheum"},{"issue":"323","key":"658_CR32","first-page":"e321","volume":"73","author":"A Elstob","year":"2018","unstructured":"Elstob A, Ejindu V, Heron CW, Kiely PDW (2018) MRI ankle and subtalar characteristics in haemochromatosis arthropathy: a case-control study. Clin Radiol 73(323):e321\u2013e328","journal-title":"Clin Radiol"},{"key":"658_CR33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bone.2005.10.001","volume":"38","author":"MG Vogiatzi","year":"2006","unstructured":"Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ (2006) Prevalence of fractures among the Thalassemia syndromes in North America. Bone 38:571\u2013575","journal-title":"Bone"},{"key":"658_CR34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.080505","volume":"24","author":"MG Vogiatzi","year":"2009","unstructured":"Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ, Thalassemia Clinical Research N (2009) Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res 24:543\u2013557","journal-title":"J Bone Miner Res"},{"key":"658_CR35","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","volume":"95","author":"AJ Burghardt","year":"2010","unstructured":"Burghardt AJ, Issever AS, Schwartz AV, Davis KA, Masharani U, Majumdar S, Link TM (2010) High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 95:5045\u20135055","journal-title":"J Clin Endocrinol Metab"},{"key":"658_CR36","doi-asserted-by":"crossref","first-page":"e0207441","DOI":"10.1371\/journal.pone.0207441","volume":"13","author":"M Simao","year":"2018","unstructured":"Simao M, Camacho A, Ostertag A, Cohen-Solal M, Pinto IJ, Porto G, Hang Korng E, Cancela ML (2018) Iron-enriched diet contributes to early onset of osteoporotic phenotype in a mouse model of hereditary hemochromatosis. PLoS ONE 13:e0207441","journal-title":"PLoS ONE"},{"key":"658_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fphar.2017.00077","volume":"8","author":"V Jeney","year":"2017","unstructured":"Jeney V (2017) Clinical impact and cellular mechanisms of iron overload-associated bone loss. Front Pharmacol 8:77","journal-title":"Front Pharmacol"},{"key":"658_CR38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/ph11040107","volume":"11","author":"E Balogh","year":"2018","unstructured":"Balogh E, Paragh G, Jeney V (2018) Influence of iron on bone homeostasis. Pharmaceuticals (Basel) 11:107","journal-title":"Pharmaceuticals (Basel)"},{"key":"658_CR39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1359\/jbmr.091002","volume":"25","author":"A Zarjou","year":"2010","unstructured":"Zarjou A, Jeney V, Arosio P, Poli M, Zavaczki E, Balla G, Balla J (2010) Ferritin ferroxidase activity: a potent inhibitor of osteogenesis. J Bone Miner Res 25:164\u2013172","journal-title":"J Bone Miner Res"},{"key":"658_CR40","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.bbadis.2016.06.003","volume":"1862","author":"E Balogh","year":"2016","unstructured":"Balogh E, Tolnai E, Nagy B Jr, Nagy B, Balla G, Balla J, Jeney V (2016) Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochim Biophys Acta 1862:1640\u20131649","journal-title":"Biochim Biophys Acta"},{"key":"658_CR41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nm.1910","volume":"15","author":"KA Ishii","year":"2009","unstructured":"Ishii KA, Fumoto T, Iwai K, Takeshita S, Ito M, Shimohata N, Aburatani H, Taketani S, Lelliott CJ, Vidal-Puig A, Ikeda K (2009) Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat Med 15:259\u2013266","journal-title":"Nat Med"},{"issue":"Pt 2","key":"658_CR42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/bj2980421","volume":"298","author":"O Alcantara","year":"1994","unstructured":"Alcantara O, Reddy SV, Roodman GD, Boldt DH (1994) Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron. Biochem J 298(Pt 2):421\u2013425","journal-title":"Biochem J"},{"key":"658_CR43","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-110-6-430","volume":"110","author":"T Diamond","year":"1989","unstructured":"Diamond T, Stiel D, Posen S (1989) Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors? Ann Intern Med 110:430\u2013436","journal-title":"Ann Intern Med"},{"key":"658_CR44","first-page":"128","volume":"5","author":"O Loreal","year":"2014","unstructured":"Loreal O, Cavey T, Bardou-Jacquet E, Guggenbuhl P, Ropert M, Brissot P (2014) Iron, hepcidin, and the metal connection. Front Pharmacol 5:128","journal-title":"Front Pharmacol"},{"key":"658_CR45","first-page":"16","volume":"14","author":"PC Adams","year":"1991","unstructured":"Adams PC, Bradley C, Frei JV (1991) Hepatic zinc in hemochromatosis. Clin Invest Med 14:16\u201320","journal-title":"Clin Invest Med"},{"key":"658_CR46","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1039\/C7MT00079K","volume":"9","author":"Q Ye","year":"2017","unstructured":"Ye Q, Park JE, Gugnani K, Betharia S, Pino-Figueroa A, Kim J (2017) Influence of iron metabolism on manganese transport and toxicity. Metallomics 9:1028\u20131046","journal-title":"Metallomics"},{"key":"658_CR47","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jinorgbio.2015.09.008","volume":"152","author":"D Chappard","year":"2015","unstructured":"Chappard D, Mabilleau G, Moukoko D, Henric N, Steiger V, Le Nay P, Frin JM, De Bodman C (2015) Aluminum and iron can be deposited in the calcified matrix of bone exostoses. J Inorg Biochem 152:174\u2013179","journal-title":"J Inorg Biochem"},{"key":"658_CR48","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.morpho.2015.12.001","volume":"100","author":"D Chappard","year":"2016","unstructured":"Chappard D, Bizot P, Mabilleau G, Hubert L (2016) Aluminum and bone: Review of new clinical circumstances associated with Al(3+) deposition in the calcified matrix of bone. Morphologie 100:95\u2013105","journal-title":"Morphologie"},{"key":"658_CR49","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.cgh.2016.12.039","volume":"15","author":"E Bardou-Jacquet","year":"2017","unstructured":"Bardou-Jacquet E, Laine F, Guggenbuhl P, Morcet J, Jezequel C, Guyader D, Moirand R, Deugnier Y (2017) Worse outcomes of patients with HFE hemochromatosis with persistent increases in transferrin saturation during maintenance therapy. Clin Gastroenterol Hepatol 15:1620\u20131627","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-020-00658-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:10:05Z","timestamp":1611619805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-020-00658-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,27]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["658"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00658-7","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,27]]},"assertion":[{"value":"10 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Nico Maximilian Jandl, Tim Rolvien, Tobias Schmidt, Haider Mussawy, Peter Nielsen, Ralf Oheim, Michael Amling, and Florian Barvencik declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the Declaration of Helsinki and approved by the local ethics committee (WF-038\/19).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}